Review

Published on 22 Apr 2024

Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Rongkun Chen
Shuyu Zhu
Ruoyu Zhao
Wang Liu
Luxin Jin
Xiaobin Ren
Hongbing He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1402514

2,387 views
3 citations

Editorial

Published on 18 Apr 2024

Editorial: New strategies for reversing cancer therapy resistance

in Pharmacology of Anti-Cancer Drugs

Yue Du
Xiujun Liu
Lulu Wang
Shengxi Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411519

680 views

Correction

Published on 18 Apr 2024

Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells

in Pharmacology of Anti-Cancer Drugs

Yaming Ding
Zhang Zhen
Muhammad Azhar Nisar
Farman Ali
Riaz Ud Din
Muhammad Khan
Tafail Akbar Mughal
Gulzar Alam
Linlin Liu
Muhammad Zubair Saleem

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1363218

667 views

Original Research

Published on 18 Apr 2024

The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort

in Pharmacology of Anti-Cancer Drugs

Qian-Rong Huang
Qian Jiang
Ju-Yuan Tan
Ren-Bao Nong
Jun Yan
Xia-Wei Yang
Li-Gen Mo
Guo-Yuan Ling
Teng Deng
Yi-Zhen Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390615

1,862 views
1 citation

Systematic Review

Published on 17 Apr 2024

Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Jingyang Su
Jialin Zhang
Yuqian Wu
Cui Ni
Yueyue Ding
Zelin Cai
Ming Xu
Mingyang Lai
Jue Wang
Shengyou Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1322473

1,764 views

Original Research

Published on 17 Apr 2024

Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets

in Pharmacology of Anti-Cancer Drugs

Haibin Tang
Liuxun Chen
Xvdong Liu
Shengjie Zeng
Hao Tan
Gang Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346719

1,478 views

Review

Published on 16 Apr 2024

The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment

in Pharmacology of Anti-Cancer Drugs

Yuanyuan Liu
Shanwu Yu
Yixiang Chen
Zhihong Hu
Lingling Fan
Gaofeng Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1376955

1,231 views

Review

Published on 12 Apr 2024

Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer

in Pharmacology of Anti-Cancer Drugs

Zhiyuan Yao
Peng Song
Wenjie Jiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1383580

1,473 views

Review

Published on 12 Apr 2024

Research progress and applications of epigenetic biomarkers in cancer

in Pharmacology of Anti-Cancer Drugs

Jianjun Gao
Wujiang Shi
Jiangang Wang
Canghai Guan
Qingfu Dong
Jialin Sheng
Xinlei Zou
Zhaoqiang Xu
Yifei Ge
Chengru Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1308309

1,792 views
1 citation

Original Research

Published on 12 Apr 2024

Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches

in Pharmacology of Anti-Cancer Drugs

Liya Feng
Sha Zhu
Jian Ma
Jing Huang
Xiaoyan Hou
Qian Qiu
Tingting Zhang
Meixia Wan
Juan Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389440

1,674 views

Editorial

Published on 11 Apr 2024

Editorial: Peptidases as a therapeutic target in anti-cancer management

in Pharmacology of Anti-Cancer Drugs

Ana Mitrović
Roberta E. Burden
Adaleta Softič
Nežka Kavčič

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1394018

593 views

Original Research

Published on 11 Apr 2024

Cymensifin A: a promising pharmaceutical candidate to defeat lung cancer via cellular reactive oxygen species-mediated apoptosis

in Pharmacology of Anti-Cancer Drugs

Bruno Cesar Costa Soares
Hnin Ei Ei Khine
Boonchoo Sritularak
Pithi Chanvorachote
Rosa Alduina
Rungroch Sungthong
Chatchai Chaotham

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361085

1,294 views

Technology and Code

Published on 11 Apr 2024

ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification

in Pharmacology of Anti-Cancer Drugs

Zesheng Li
Cheng Wei
Zhenyu Zhang
Lei Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375112

1,072 views

Review

Published on 10 Apr 2024

Metabolic vulnerability of cancer stem cells and their niche

in Pharmacology of Anti-Cancer Drugs

Laura Marrone
Simona Romano
Chiara Malasomma
Valeria Di Giacomo
Andrea Cerullo
Rosetta Abate
Marialuisa Alessandra Vecchione
Deborah Fratantonio
Maria Fiammetta Romano

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1375993

1,646 views

Case Report

Published on 10 Apr 2024

Case report: Robust response to sintilimab in advanced distal cholangiocarcinoma with PD-L1 expression and DNA damage repair

in Pharmacology of Anti-Cancer Drugs

Wenguang He
Congcong Song
Jiwei Ren
Xiao Ji
Xiuyan Wang
Lixia Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1336699

897 views
1 citation

Original Research

Published on 10 Apr 2024

Machine learning-based identification of a consensus immune-derived gene signature to improve head and neck squamous cell carcinoma therapy and outcome

in Pharmacology of Anti-Cancer Drugs

Xueying Hu
Haiqun Dong
Wen Qin
Ying Bin
Wenhua Huang
Min Kang
Rensheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1341346

1,381 views
1 citation

Navigation group

Articles

Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma

Editorial: New strategies for reversing cancer therapy resistance

Corrigendum: Sesquiterpene lactones attenuate paclitaxel resistance via inhibiting MALAT1/STAT3/ FUT4 axis and P-Glycoprotein transporters in lung cancer cells

The prognostic and immunological role of MCM3 in pan-cancer and validation of prognosis in a clinical lower-grade glioma cohort

Cabozantinib in combination with immune checkpoint inhibitors for renal cell carcinoma: a systematic review and meta-analysis

Pan-cancer dissection of vasculogenic mimicry characteristic to provide potential therapeutic targets

The clinical regimens and cell membrane camouflaged nanodrug delivery systems in hematologic malignancies treatment

Pathogenic role of super-enhancers as potential therapeutic targets in lung cancer

Research progress and applications of epigenetic biomarkers in cancer

Small molecule drug discovery for glioblastoma treatment based on bioinformatics and cheminformatics approaches

Editorial: Peptidases as a therapeutic target in anti-cancer management

Cymensifin A: a promising pharmaceutical candidate to defeat lung cancer via cellular reactive oxygen species-mediated apoptosis

ecGBMsub: an integrative stacking ensemble model framework based on eccDNA molecular profiling for improving IDH wild-type glioblastoma molecular subtype classification

Metabolic vulnerability of cancer stem cells and their niche

Case report: Robust response to sintilimab in advanced distal cholangiocarcinoma with PD-L1 expression and DNA damage repair

Machine learning-based identification of a consensus immune-derived gene signature to improve head and neck squamous cell carcinoma therapy and outcome